Definium Therapeutics (DFTX) Shares Outstanding (2019 - 2026)

Definium Therapeutics (DFTX) has 8 years of Shares Outstanding data on file, last reported at $104.0 million in Q1 2026.

• Quarterly Shares Outstanding rose 37.79% year-over-year to $104.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $104.0 million (up 37.79% YoY) and the FY2025 annual result came in at $98.8 million, up 31.52% from the prior year.
• Shares Outstanding improved to $104.0 million in Q1 2026 per DFTX's latest filing, from $98.8 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $104.0 million in Q1 2026 and bottomed at $28.2 million in Q1 2022.
• The 5-year median for Shares Outstanding is $71.2 million (2024), against an average of $60.1 million.
• The widest annual swing landed in 2022, when Shares Outstanding jumped 11968.64%; it then tumbled 95.14% in 2025.
• Tracing DFTX's Shares Outstanding over 5 years: stood at $38.0 million in 2022, then gained by 8.22% to $41.1 million in 2023, then jumped by 82.72% to $75.1 million in 2024, then jumped by 31.52% to $98.8 million in 2025, then climbed by 5.33% to $104.0 million in 2026.
• Per Business Quant, the three latest DFTX Shares Outstanding figures stand at $104.0 million (Q1 2026), $98.8 million (Q4 2025), and $76.8 million (Q3 2025).

Peer Comparison